Pfizer Halts Enrollment in Cancer-Drug Trial


October 12, 2009

The Wall Street Journal

Pfizer Inc. temporarily halted enrollment of new patients in a clinical trial of an experimental lung-cancer drug, saying the drug was associated with a higher rate of adverse events, including fatalities, than for patients who didn't get the drug... Read More (access restricted)